Sacubitril/Valsartan in Patients With Heart Failure and Concomitant End‐Stage Kidney Disease
Sacubitril/Valsartan in Patients With Heart Failure and Concomitant End‐Stage Kidney Disease is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Sacubitril/Valsartan in Patients With Heart Failure and Concomitant End‐Stage Kidney Disease have?
Sacubitril/Valsartan in Patients With Heart Failure and Concomitant End‐Stage Kidney Disease has 62 citations in the OpenAlex counts ScholarIQ stores.
When was Sacubitril/Valsartan in Patients With Heart Failure and Concomitant End‐Stage Kidney Disease published?
Sacubitril/Valsartan in Patients With Heart Failure and Concomitant End‐Stage Kidney Disease has 2022 year in the ScholarIQ index.
What is the open-access status of Sacubitril/Valsartan in Patients With Heart Failure and Concomitant End‐Stage Kidney Disease?
Sacubitril/Valsartan in Patients With Heart Failure and Concomitant End‐Stage Kidney Disease has gold oa status in the ScholarIQ index.
What is the DOI of Sacubitril/Valsartan in Patients With Heart Failure and Concomitant End‐Stage Kidney Disease?
The DOI for Sacubitril/Valsartan in Patients With Heart Failure and Concomitant End‐Stage Kidney Disease is on the source record.
What is the PMID of Sacubitril/Valsartan in Patients With Heart Failure and Concomitant End‐Stage Kidney Disease?
The PMID for Sacubitril/Valsartan in Patients With Heart Failure and Concomitant End‐Stage Kidney Disease is on the source record.
What is the OpenAlex record for Sacubitril/Valsartan in Patients With Heart Failure and Concomitant End‐Stage Kidney Disease?
The OpenAlex for Sacubitril/Valsartan in Patients With Heart Failure and Concomitant End‐Stage Kidney Disease is on the source record.